Mednet Logo
Community

Would you consider maintenance immunotherapy following chemoradiation for a patient with an isolated mediastinal recurrence of NSCLC?

Community PollStarted

How do you managed an isolated mediastinal recurrence of NSCLC?

53 physicians have voted

Join Mednetto vote and see how they answered.

1 Answer
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · The Ohio State University School of Medicine
Answered on

For patients with loco-regional recurrent NSCLC treated with definitive chemoradiation, I would offer durvalumab consolidation since I would consider this on-label treatment (i.e inoperable stage III NSCLC - even TxN2 - treated with definitive chemoradiation). Other nuances of N2 NSCLC in the era of...

Join for free or sign in to see the full answer